The objective of administering an erythropoiesis-stimulating agent is to keep hemoglobin at the lowest level which minimizes transfusions and meets the needs of the individual. They are not recommended in people with chronic kidney disease, unless hemoglobin levels are less than 10 g / dL or have symptoms of anemia.Continue Reading